MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$7,797K Prepaid expense andother current assets$934K Accounts receivable, net$161K Ppe$93K Total current assets$8,892K Goodwill (provisional)$1,793K Intangible assets, net(provisional)$925K Right-of-use assets,net-Nonrelated Party$414K Investments$397K Other assets$253K Right-of-use assets,net-Related Party$219K Furniture and equipment,net$63K Less accumulateddepreciation$30K Total assets$12,956K Accumulated deficit-$306,895K Nrx Segment$23K Dura Segment$7K Total liabilities andstockholders' deficit$12,956K Total stockholdersdeficit-$15,937K Additional paid-in capital$290,926K Common stock, 0.001 parvalue, 500,000,000...$32K Total liabilities$28,893K Total currentliabilities$28,578K Lease liability,noncurrent-Nonrelated Party$199K Lease liability,noncurrent-Related Party$116K Warrant liabilities$12,304K Accrued and othercurrent liabilities$11,337K Accounts payable$4,270K Accrued clinical sitecosts$351K Lease liability,short...$211K Lease liability,short term-Related...$105K
Balance Sheet
source: myfinsight.com

NRX Pharmaceuticals, Inc. (NRXPW)

NRX Pharmaceuticals, Inc. (NRXPW)